HDL: Still a target for therapy? PaACC Annual Chapter Meeting November 2, 2008 Daniel J. Rader, MD University of Pennsylvania School of Medicine [email protected].
LIPID LOWERING IN T2D (The Lower the Better?) CONS… TARGETING HARD CVD END POINTS Charles SAAB MD Consultant Endocrinologist DCRP Sacre-Coeur University.
